Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Wound Healing Results Timeline Comparison

Hemostasis & Early Inflammation Days 0–3 No visible change; growth factor upregulation begins No visible change VEGF mRNA ↑, endothelial progenitor mobilization Cellular prep phase. Effects not yet observable Angiogenesis & Granulation Days 3–7 30–56% faster w

This comparison does not assign a generated winner or score.

  • Hemostasis & Early Inflammation
  • Days 0–3
  • No visible change; growth factor upregulation begins
  • No visible change
  • VEGF mRNA ↑, endothelial progenitor mobilization
  • Cellular prep phase. Effects not yet observable
  • Angiogenesis & Granulation
  • Days 3–7
  • 30–56% faster wound closure; reduced gaping
  • Minimal closure; persistent exudate
  • VEGFR-2 activation, capillary formation
  • First measurable improvement window
  • Proliferative Phase Peak
  • Days 7–14
  • Complete epithelialization 2–3 days earlier; 40% ↑ collagen content
  • Partial closure; weaker matrix
  • FAK-paxillin pathway, fibroblast migration
  • Structural strength gains become evident
  • Collagen Remodeling
  • Weeks 2–4
  • Reduced fibrosis; improved scar flexibility
  • Standard remodeling; risk of hypertrophic scar
  • TGF-β modulation, Type I collagen conversion
  • Determines long-term tissue quality
  • Maturation
  • Weeks 4–12
  • Continued strength gains if dosing maintained
  • 70–80% original strength
  • Gradual collagen alignment
  • Diminishing returns after week 4
More references

Related material